-+ 0.00%
-+ 0.00%
-+ 0.00%

Roivant Sciences President and Immunovant CEO Eric Venker Reports $7.62 Million Common Share Disposal

PUBT·11/13/2026 00:01:01
Listen to the news
Roivant Sciences President and Immunovant CEO Eric Venker Reports $7.62 Million Common Share Disposal
  • Roivant Sciences President and Immunovant CEO Eric Venker sold 187,943 common shares on Nov. 10, 2026.
  • The sales comprised 158,194 shares at $40.44 per share and 29,749 shares at $41 per share.
  • Venker retained direct ownership of 811,211 common shares, according to the Form 4 dated Nov. 12, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001635088-26-000137), on November 12, 2026, and is solely responsible for the information contained therein.